SASTASUNDR2024-04-012024-06-30 SASTASUNDR2024-04-012024-06-30in-bse-fin:OneOtherRevenueFromOperations01Member SASTASUNDR2024-04-012024-06-30in-bse-fin:OneOperatingExpenses01Member SASTASUNDR2024-06-30 SASTASUNDR2024-04-012024-06-30in-bse-fin:OneReportableSegmentRevenue01Member SASTASUNDR2024-04-012024-06-30in-bse-fin:OneReportableSegmentRevenue02Member SASTASUNDR2024-04-012024-06-30in-bse-fin:OneReportableSegmentResults01Member SASTASUNDR2024-04-012024-06-30in-bse-fin:OneReportableSegmentResults02Member SASTASUNDR2024-04-012024-06-30in-bse-fin:OneReportableSegmentAssets01Member SASTASUNDR2024-04-012024-06-30in-bse-fin:OneReportableSegmentAssets02Member SASTASUNDR2024-04-012024-06-30in-bse-fin:OneReportableSegmentLiabilities01Member SASTASUNDR2024-06-30in-bse-fin:OneReportableSegmentLiabilities01Member SASTASUNDR2024-04-012024-06-30in-bse-fin:OneReportableSegmentLiabilities02Member SASTASUNDR2024-06-30in-bse-fin:OneReportableSegmentLiabilities02Member SASTASUNDR2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 533259 SASTASUNDR NOTLISTED Sastasundar Ventures Limited Equity 2024-04-01 2025-03-31 2024-07-29 2024-07-23 INR Lakhs First quarter 2024-07-29 15:45:00 2024-07-29 18:15:00 false Not applicable Multi segment 2024-04-01 2024-06-30 Unaudited Consolidated 1875000.00 264000.00 0.00 0.00 71004000.00 0.00 2619935000.00 8706000.00 1145000.00 2702929000.00 277499000.00 2980428000.00 6182000.00 2447674000.00 -26636000.00 106191000.00 967000.00 16080000.00 0.00 0.00 0.00 0.00 193537000.00 2743995000.00 236433000.00 10000000.00 246433000.00 9121000.00 -262381000.00 -253260000.00 499693000.00 0.00 0.00 0.00 -90035000.00 409658000.00 2607000.00 412265000.00 311512000.00 98146000.00 313415000.00 98850000.00 318105000.00 10 9.79 9.79 0.00 0.00 9.79 9.79 0.00 0.00 0.00 4. Happymate Foods Limited, step down subsidiary of the company had started its operation in fast moving consumer goods in 2018 with an aim to reach the consumer with a premium brand. The company has taken various steps since then to build distribution channel & offline stores, which did not turn out as expected and losses has been incurred. Presently the company is into discussion with business partner on further plans of restructuring its business. 5. During the previous year, the Board of Directors at its meeting held on 21st March, 2024 approved a Scheme of Arrangement (the Scheme) for amalgamation of Retailer Shakti Supply Chain Private Limited (Transferor Company) (the Step down Subsidiary) with Sastasundar Healthbuddy Limited (“Transferee Company”) (subsidiary Company) under Sections 230 to 232 and other relevant provisions of the Companies Act, 2013 and the rules made there under, with effect from 1st April, 2023 (the Appointed Date). The Scheme is subject to requisite approvals of the concerned regulatory authorities. Pending such approvals, the scheme has not been recognised in these financial statements. 6. During the previous year, Sastasundar Healthbuddy Limited (SHBL) subsidiary of the Company's has received 99,873 number of 0.01% Non-Cumulative Compulsorily Convertible Preference Shares (CCPS) from its associate (erstwhile wholly owned subsidiary) in the earlier financial year. SHBL has entered into a Put Call Option Agreement on 19 November 2021 with its associate and the purchaser (‘the investor’) (the Holding Company of the associate) whereby it agreed to sell 75.1% of the aforesaid CCPS (‘milestone shares’) to the investor at a specified consideration on achievement of certain milestones on or before the milestone event target dates by the Company. The put call option agreement was subsequently amended on 3 March 2022 and 17 April 2023. As per the last amendment, SHBL agreed to transfer 12,612 CCPS to the investor for an agreed consideration, against which Rs. 1,669.23 Lakhs was received in May 2023, and 4,182 CCPS to be converted into equity shares of the associate as per the conversion ratio defined in the agreement, post achievement of the specified milestones. With respect to the remaining CCPS, it was decided that SHBL, the associate and the investor will mutually discuss and agree in writing the terms and conditions of the remaining milestone events, milestone shares and milestone consideration. The maximum overall consideration payable for all milestones has been specified by the amendment agreement dated 17 April 2023 which is in line with the amended Put Call Option Agreement dated 3 March 2022. The management, based on its internal assessment and best estimate of milestone events, milestone shares and milestone consideration, has derived the fair value of the investment for the aforesaid CCPS by engaging an independent registered valuer. 7. During the Quarter ended June 2024, the company has reversed Deferred Tax Liabilities amounting to Rs. 2,623.81 Lakhs under the heading Deferred tax expense / (credit) in the consolidated financial results. The reversal majorly includes benefits arising from change in taxation on long term capital gain on unlisted securities under the Finance (No. 2) Bill, 2024 presented on 23rd July 2024. 8. The figure for the quarter ended 31st March, 2024 are the balancing figure between audited figure in respect of the full financial year and the unaudited published period to date reviewed figures upto the end of the third quarter 31st December, 2023 which were subjected to a limited review. 9. Previous Period/ Year figures have been re-grouped / re-classified wherever necessary. Other financial income 1145000.00 Other Expenses 193537000.00 0.00 0.00 0.00 0.00 Financial Services 74288000.00 Healthcare Network 2628641000.00 2702929000.00 2702929000.00 Financial Services 68102000.00 Healthcare Network -87560000.00 -19458000.00 967000.00 -266858000.00 246433000.00 Financial Services 914279000.00 Healthcare Network 10489797000.00 11404076000.00 404413000.00 11808489000.00 Financial Services 38428000.00 Healthcare Network 1319307000.00 1357735000.00 43147000.00 1400882000.00 1. The above Unaudited Consolidated Financial Results for the quarter ended June 30, 2024 have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on July 29, 2024. The Limited Review for the quarter ended June 30, 2024 has been carried out by the Statutory Auditors, as required under Regulation 33 of SEBI (LODR) Regulation, 2015. 2. The Group has identified the following segments : (a) Financial Services - consists mainly of financing of loans and investment in shares and securities, financial consultancy, professional fees, wealth management, financial planning, distribution and related services. (b) Healthcare Network - includes activities for pathology and marketing of healthcare and OTC products through e-commerce portal and diagnostic services which consist of pathological / radiological investigations. 3. Exceptional items represent the gain on following transaction/ event: During the Financial Year 22-23, subsidiaries of the Company had expensed Rs 796.45 Lakhs under the heading “Exceptional Item”. Sastasundar Healthbuddy Limited, subsidiary of the Company has now recovered Rs. 100.00 Lakhs against the aforesaid amount which has been booked as income in the Current Quarter under the heading “exceptional item” Remeasurement gain/ (loss) on defined benefit plans (net of tax) 2598000.00 2598000.00 -9000.00 0.00 2607000.00